Russell Investments Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3K | Sell |
1,532
-17,137
| -92% | -$350K | ﹤0.01% | 3094 |
|
|
2025
Q1 | $373K | Buy |
18,669
+11,457
| +159% | +$229K | ﹤0.01% | 2397 |
|
|
2024
Q4 | $192K | Sell |
7,212
-18,162
| -72% | -$484K | ﹤0.01% | 2547 |
|
|
2024
Q3 | $724K | Sell |
25,374
-9,131
| -26% | -$260K | ﹤0.01% | 2151 |
|
|
2024
Q2 | $751K | Buy |
34,505
+2,812
| +9% | +$61.2K | ﹤0.01% | 2075 |
|
|
2024
Q1 | $702K | Sell |
31,693
-290
| -0.9% | -$6.42K | ﹤0.01% | 2099 |
|
|
2023
Q4 | $690K | Buy |
31,983
+2,998
| +10% | +$64.7K | ﹤0.01% | 2117 |
|
|
2023
Q3 | $490K | Buy |
28,985
+21,265
| +275% | +$359K | ﹤0.01% | 2233 |
|
|
2023
Q2 | $106K | Buy |
+7,720
| New | +$106K | ﹤0.01% | 2595 |
|
|
2022
Q4 | – | Sell |
-86,551
| Closed | -$2.26M | – | 2909 |
|
|
2022
Q3 | $2.26M | Buy |
+86,551
| New | +$2.26M | 0.01% | 1484 |
|
|
2021
Q4 | – | Sell |
-88,774
| Closed | -$5.9M | – | 3012 |
|
|
2021
Q3 | $5.9M | Buy |
88,774
+10,877
| +14% | +$723K | 0.01% | 1153 |
|
|
2021
Q2 | $5.71M | Sell |
77,897
-2,114
| -3% | -$155K | 0.01% | 1268 |
|
|
2021
Q1 | $5.48M | Sell |
80,011
-30,374
| -28% | -$2.08M | 0.01% | 1323 |
|
|
2020
Q4 | $7.41M | Buy |
110,385
+1,436
| +1% | +$96.4K | 0.01% | 1033 |
|
|
2020
Q3 | $5.6M | Buy |
108,949
+18,595
| +21% | +$956K | 0.01% | 1070 |
|
|
2020
Q2 | $3.4M | Buy |
90,354
+13,986
| +18% | +$527K | 0.01% | 1321 |
|
|
2020
Q1 | $2.27M | Buy |
76,368
+22,745
| +42% | +$677K | 0.01% | 1398 |
|
|
2019
Q4 | $1.84M | Buy |
53,623
+36,305
| +210% | +$1.25M | ﹤0.01% | 1793 |
|
|
2019
Q3 | $313K | Buy |
+17,318
| New | +$313K | ﹤0.01% | 2453 |
|